3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
80
Neoplasm Metastasis
6
Neoplasms
3
Breast Neoplasms, Male
3
Arthralgia
2
Triple Negative Breast Neoplasms
1
Sleep Wake Disorders
1
Skin Diseases
1
Prostatic Neoplasms
1
Post Menopausal Women With Early Breast Cancer
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Obesity
1
Metastatic Beast Cancer
1
Mammary Neoplasms, Animal
1
Lymphoma
1
Lethal Congenital Contracture Syndrome 2
1
Invasive Early Breast Cancer
1
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
1
Fatigue
1
Estrogen-receptor Positive Invasive Metastatic Breast Cancer
1
Endometrial Neoplasms
1
Endometrial Hyperplasia
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Diseases
1
Breast Carcinoma In Situ
1
Breast Cancer Metastatic
1
Advanced Breast Carcinoma
1
Interventions
Alpelisib
4
berzosertib
3
Fulvestrant
3
Everolimus
3
parsaclisib
2
Topotecan
2
NVP-BKM120
2
Cetuximab
2
talazoparib
1
sotorasib
1
serabelisib
1
ruxolitinib
1
duvelisib
1
dapagliflozin
1
cobimetinib
1
ceralasertib
1
binimetinib
1
avelumab
1
Vemurafenib
1
SF 1126
1
Rituximab
1
Paclitaxel
1
Oxaliplatin
1
Leuprolide
1
Leucovorin
1
Letrozole
1
Irinotecan
1
Goserelin
1
Fluorouracil
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hereditary Sensory and Autonomic Neuropathies
×
exemestane
×
Clear all
No trials found.